« Back to Record
Citation APA

Twelves, C., Awada, A., Cortes, J., Yelle, L., Velikova, G., Olivo, M. M., Song, J., Dutcus, C. C., & Kaufman, P. P. (2016). Subgroup analyses from a phase 3, open-label, randomized study of eribulin mesylate versus capecitabine in pretreated patients with advanced or metastatic breast cancer. Breast Cancer, 10, 77-84. doi:10.4137/BCBCR.S39615


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/240409

Twelves, C., Awada, A., Cortes, J., Yelle, L., Velikova, G., Olivo, M. M., Song, J., Dutcus, C. C., & Kaufman, P. P. (2016). Subgroup analyses from a phase 3, open-label, randomized study of eribulin mesylate versus capecitabine in pretreated patients with advanced or metastatic breast cancer. Breast Cancer, 10, 77-84. doi:10.4137/BCBCR.S39615